Incidence and Complications of Post-extubation and Post-tracheostomy Dysphagia in Adult Patients in the Critical Care Unit
Launched by COMPLEJO HOSPITALARIO UNIVERSITARIO DE ALBACETE · Sep 3, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called post-extubation dysphagia, which means difficulty swallowing that can occur after patients have been on a breathing tube or have had a tracheostomy (a procedure where a hole is made in the neck for breathing). This problem can lead to serious issues like lung infections, malnutrition, and even longer hospital stays or worse outcomes. The researchers want to find out how common this swallowing difficulty is in patients who were intubated for more than 48 hours or who had a tracheostomy, as well as how it affects their overall health and quality of life.
To participate in the study, you must be at least 18 years old, have been intubated for at least two days or had a tracheostomy, and be able to understand and take a swallowing test. Participants will undergo assessments to see how well they are swallowing and may answer questions about their quality of life during their hospital stay and after leaving the intensive care unit. This research aims to provide better insights into the complications related to swallowing difficulties in critically ill patients and improve their care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged ≥ 18 years, requiring intubation for ≥ 48 hours and/or subsequent tracheostomy, with an adequate level of consciousness to perform the dysphagia diagnostic test, and who have signed the consent form.
- Exclusion Criteria:
- • Previous tracheostomy, prior diagnosis of dysphagia, neurodegenerative disease, or a history of stroke (CVA).
About Complejo Hospitalario Universitario De Albacete
The Complejo Hospitalario Universitario de Albacete is a prominent healthcare institution in Spain, dedicated to providing high-quality medical care and advancing clinical research. As a university hospital, it integrates comprehensive patient services with academic training and research initiatives, fostering innovation in medical practices. The institution is committed to enhancing health outcomes through rigorous clinical trials that explore new therapies and treatment methodologies, thereby contributing to the broader medical community and improving patient care standards. With a multidisciplinary team of healthcare professionals, the hospital plays a pivotal role in advancing medical knowledge and ensuring evidence-based practices within the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported